S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14

Dr. Hönle (HNL) Stock Forecast, Price & News

+1.30 (+5.99%)
(As of 05/18/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
7,190 shs
Average Volume
Market Capitalization
$139.42 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive HNL News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter.

About Dr. Hönle

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.


No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Electronic Components
Year Founded

Sales & Book Value

Annual Sales
$121.98 million
Cash Flow
€1.20 per share
Book Value
€18.90 per share


Pretax Margin




Free Float
Market Cap
$139.42 million
Not Optionable

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.50 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Dr. Hönle (ETR:HNL) Frequently Asked Questions

Is Dr. Hönle a buy right now?

0 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Hönle in the last twelve months. There are currently for the stock. The consensus among Wall Street research analysts is that investors should "n/a" Dr. Hönle stock.
View analyst ratings for Dr. Hönle
or view top-rated stocks.

When is Dr. Hönle's next earnings date?

Dr. Hönle is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Dr. Hönle

Is Dr. Hönle a good dividend stock?

Dr. Hönle pays an annual dividend of €0.20 per share and currently has a dividend yield of 0.86%.

What price target have analysts set for HNL?

0 Wall Street analysts have issued 12-month target prices for Dr. Hönle's shares. Their forecasts range from €62.00 to €64.00. On average, they expect Dr. Hönle's share price to reach €63.00 in the next twelve months. This suggests a possible upside of 173.9% from the stock's current price.
View analysts' price targets for Dr. Hönle
or view top-rated stocks among Wall Street analysts.

Who are Dr. Hönle's key executives?
Dr. Hönle's management team includes the following people:
  • Dr. Norbert Haimerl M.B.A., CFO, MD of Investor Relations, Logistics & Quality Management and Member of Management Board (Age 60, Pay $697k)
  • Mr. Heiko Runge Grad. Eng., MD of Sales & Marketing and Member of Management Board (Age 58, Pay $662k)
  • Mr. Rainer Pumpe, MD of Devel. & Production and Member of the Management Board (Age 54, Pay $331.94k)
  • Peter Weinert, Head of Investor Relations
What is Dr. Hönle's stock symbol?

Dr. Hönle trades on the ETR under the ticker symbol "HNL."

What is Dr. Hönle's stock price today?

One share of HNL stock can currently be purchased for approximately €23.00.

How much money does Dr. Hönle make?

Dr. Hönle has a market capitalization of $139.42 million and generates $121.98 million in revenue each year.

How many employees does Dr. Hönle have?

Dr. Hönle employs 657 workers across the globe.

What is Dr. Hönle's official website?

The official website for Dr. Hönle is www.hoenle.de.

How can I contact Dr. Hönle?

The company can be reached via phone at 49 89 85608 0.

This page was last updated on 5/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.